Christopher P. Cochran serves as Executive at Coeptis Therapeutics Holdings, Inc., where they oversee executive responsibilities. Since joining the company, Christopher P. Cochran has executed 1 insider transactions totaling $5.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 5, 2024 involved purchasing 7,000 shares valued at $5.4K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 5, 2024 | COEP | $5.4K | Purchase | 7,000 | $0.77 | Discretionary |
Christopher P. Cochran currently holds 37,000 shares of Coeptis Therapeutics Holdings, Inc. (COEP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher P. Cochran has been a net buyer of COEP stock. They have purchased $5.4K and sold $0 worth of shares.
Christopher P. Cochran's most recent insider trade was on Jan 5, 2024, when they purchased 7,000 shares at $0.77 per share.
Get notified when new Form 4 filings are submitted